Skip to main content
. 2020 Aug 17;12(8):e9799. doi: 10.7759/cureus.9799

Table 3. Clinical outcomes of ACS hospitalizations with and without RA.

PTCA: percutaneous transluminal coronary angioplasty; PCI DES: percutaneous coronary intervention with drug-eluting stent; PCI BMS: percutaneous coronary intervention with bare-metal stent; IABP: intra-aortic balloon pump; PEAD: percutaneous external assist devices; thrombolytics: intracoronary artery thrombolytic infusion; CABG: coronary artery bypass graft; OR: odds ratio; CI: confidence interval; USD: United States dollars

* statistically significant  

  ACS with RA (n=22,615) ACS without RA (n=1,296,849) Adjusted OR   p-value
  % %  (95% CI)  
Primary outcome        
 In-hospital mortality 4.5 4.6   0.84 (0.72-0.99)   0.034*
Secondary outcomes        
 PTCA 4.3 5.1 0.94 (0.81-1.10) 0.451
 PCI DES 35.4 40.5 1.14 (1.07-1.23) <0.0001*
 PCI BMS 7.1 7.9 1.01 (0.90-1.14) 0.884
 IABP 2.8 4.0 0.78 (0.64-0.95) 0.015*
 PEAD 0.88 1.0 1.07 (0.77-1.48) 0.697
 Thrombolytics 0.24 0.29 1.07 (0.56-2.05) 0.836
 CABG 6.9 8.1 0.95 (0.83-1.09) 0.473
      Adjusted mean difference  
LOS, mean days 4.6 4.4   -0.18 (- {0.32- 0.05} 0.009*
Total charge, mean, USD 85,273 91,889   -888 ({-3845}-2070) 0.556